<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Effects of Acetazolamide on Infantile Nystagmus Syndrome Waveforms: Comparisons to Contact Lenses and Convergence in a Well-Studied Subject</title>
			</titleStmt>
			<publicationStmt>
				<publisher>Bentham Science Publishers Ltd.</publisher>
				<availability status="unknown"><p>Copyright Bentham Science Publishers Ltd.</p>
				</availability>
				<date type="published" when="2010-08-31">2010-08-31</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">J</forename><surname>Thurtell</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Veterans Affairs Medical Center</orgName>
								<orgName type="department" key="dep2">CASE Medical School</orgName>
								<orgName type="laboratory">Daroff-Dell&apos;Osso Ocular Motility Laboratory</orgName>
								<address>
									<addrLine>Louis Stokes Cleveland</addrLine>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Departments of Neurology</orgName>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">F</forename><surname>Dell'osso</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Veterans Affairs Medical Center</orgName>
								<orgName type="department" key="dep2">CASE Medical School</orgName>
								<orgName type="laboratory">Daroff-Dell&apos;Osso Ocular Motility Laboratory</orgName>
								<address>
									<addrLine>Louis Stokes Cleveland</addrLine>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Departments of Neurology</orgName>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Biomedical Engineering</orgName>
								<orgName type="institution">Case Western Reserve University and University Hospitals Case Medical Center</orgName>
								<address>
									<settlement>Cleveland</settlement>
									<region>OH</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">J</forename><surname>Leigh</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Veterans Affairs Medical Center</orgName>
								<orgName type="department" key="dep2">CASE Medical School</orgName>
								<orgName type="laboratory">Daroff-Dell&apos;Osso Ocular Motility Laboratory</orgName>
								<address>
									<addrLine>Louis Stokes Cleveland</addrLine>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Departments of Neurology</orgName>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Biomedical Engineering</orgName>
								<orgName type="institution">Case Western Reserve University and University Hospitals Case Medical Center</orgName>
								<address>
									<settlement>Cleveland</settlement>
									<region>OH</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Matta</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Veterans Affairs Medical Center</orgName>
								<orgName type="department" key="dep2">CASE Medical School</orgName>
								<orgName type="laboratory">Daroff-Dell&apos;Osso Ocular Motility Laboratory</orgName>
								<address>
									<addrLine>Louis Stokes Cleveland</addrLine>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Clinical Neurology</orgName>
								<orgName type="department" key="dep2">Department of Neuroscience</orgName>
								<orgName type="institution">the University of Sassari</orgName>
								<address>
									<settlement>Sassari</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">B</forename><surname>Jacobs</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Veterans Affairs Medical Center</orgName>
								<orgName type="department" key="dep2">CASE Medical School</orgName>
								<orgName type="laboratory">Daroff-Dell&apos;Osso Ocular Motility Laboratory</orgName>
								<address>
									<addrLine>Louis Stokes Cleveland</addrLine>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Departments of Neurology</orgName>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">L</forename><surname>Tomsak</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Veterans Affairs Medical Center</orgName>
								<orgName type="department" key="dep2">CASE Medical School</orgName>
								<orgName type="laboratory">Daroff-Dell&apos;Osso Ocular Motility Laboratory</orgName>
								<address>
									<addrLine>Louis Stokes Cleveland</addrLine>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Departments of Neurology</orgName>
							</affiliation>
						</author>
						<title level="a" type="main">Effects of Acetazolamide on Infantile Nystagmus Syndrome Waveforms: Comparisons to Contact Lenses and Convergence in a Well-Studied Subject</title>
					</analytic>
					<monogr>
						<title level="j" type="main">The Open Ophthalmology Journal</title>
						<title level="j" type="abbrev">TOOPHTJ</title>
						<idno type="ISSN">1874-3641</idno>
						<imprint>
							<publisher>Bentham Science Publishers Ltd.</publisher>
							<biblScope unit="volume">4</biblScope>
							<biblScope unit="issue">1</biblScope>
							<biblScope unit="page" from="42" to="51"/>
							<date type="published" when="2010-08-31" />
						</imprint>
					</monogr>
					<idno type="DOI">10.2174/1874364101004010042</idno>
					<idno type="PMID">21270949</idno>
					<idno type="PMCID">PMC3027082</idno>
					<ptr type="open-access" target="http://benthamopen.com/contents/pdf/TOOPHTJ/TOOPHTJ-4-42.pdf" />
					<note type="submission">Received: December 13, 2009 Revised: January 26, 2010 Accepted: January 29, 2010</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-13T21:33+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Infantile nystagmus syndrome</term>
					<term>waveforms</term>
					<term>foveation</term>
					<term>drug</term>
				</keywords>
			</textClass>
			<abstract>
				<p>Aim: To determine if acetazolamide, an effective treatment for certain inherited channelopathies, has therapeutic effects on infantile nystagmus syndrome (INS) in a well-studied subject, compare them to other therapies in the same subject and to tenotomy and reattachment (T&amp;R) in other subjects. Methods: Eye-movement data were taken using a high-speed digital video recording system. Nystagmus waveforms were analyzed by applying an eXpanded Nystagmus Acuity Function (NAFX) at different gaze angles and determining the Longest Foveation Domain (LFD). Results: Acetazolamide improved foveation by both a 59.7% increase in the peak value of the NAFX function (from 0.395 to 0.580) and a 70% broadening of the NAFX vs Gaze Angle curve (the LFD increased from 20° to 34°). The resulting U-shaped improvement in the percent NAFX vs Gaze Angle curve, varied from ~60% near the NAFX peak to over 1000% laterally. The therapeutic improvements in NAFX from acetazolamide (similar to T&amp;R) were intermediate between those of soft contact lenses and convergence, the latter was best; for LFD improvements, acetazolamide and contact lenses were equivalent and less effective than convergence. Computer simulations suggested that damping the central oscillation driving INS was insufficient to produce the foveation improvements and increased NAFX values. Conclusion: Acetazolamide resulted in improved-foveation INS waveforms over a broadened range of gaze angles, probably acting at more than one site. This raises the question of whether hereditary INS involves an inherited channelopathy, and whether other agents with known effects on ion channels should be investigated as therapy for this condition.</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p>Infantile nystagmus syndrome (INS) <ref type="bibr" target="#b0">[1]</ref> is an ocular motor oscillation with well-defined waveforms and characteristics <ref type="bibr" target="#b1">[2]</ref>. The pathogenesis of INS is unknown, but in some it is an inherited disorder in which several modes of inheritance have been identified <ref type="bibr" target="#b2">[3]</ref>. The oscillations may be present at birth but often develop during early childhood and persist to some degree, despite the best current therapy. Although adaptive strategies often develop, such as foveation periods <ref type="bibr" target="#b3">[4]</ref>, the basic oscillations persist. Therapeutically, several approaches have been successfully employed to improve INS waveforms and expand the range of gaze angles with higher acuity <ref type="bibr" target="#b4">[5,</ref><ref type="bibr" target="#b5">6]</ref>. They include surgical <ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref>, optical <ref type="bibr" target="#b9">[10]</ref>, and pharmaceutical <ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref> therapies.</p><p>*Address correspondence to this author at the Daroff-Dell'Osso Ocular Motility Laboratory, Louis Stokes Department of Cleveland Veterans Affairs Medical Center, 10701 East Boulevard, Cleveland, OH 44106 USA; Tel: (216) 421-3224; Fax: (216) 231-3461; E-mail: lfd@case.edu Several underlying functional mechanisms for INS have been postulated and subsequently eliminated by ocular motor studies except one, loss of smooth-pursuit damping <ref type="bibr" target="#b13">[14,</ref><ref type="bibr" target="#b14">15]</ref>. This has been hypothesized to be the direct, functional cause of INS in all patients, whether or not they have associated, and precipitating afferent visual or genetic deficits. The hypothesized loss of smooth-pursuit damping was supported when embodied in a behavioral ocular motor system model that exhibited many emergent properties (not designed into it) <ref type="bibr" target="#b14">[15]</ref>. It was further strengthened when the model subsequently predicted both the different INS responses to the same stimulus (based on its timing with regard to the INS cycle) <ref type="bibr" target="#b15">[16,</ref><ref type="bibr" target="#b16">17]</ref> and the therapeutic results of the tenotomy and reattachment (T&amp;R) procedure <ref type="bibr" target="#b7">[8,</ref><ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref>. However, even if this functional hypothesis proves to be accurate, the pursuit-system instability itself could be the result of one or more abnormalities at the cellular or neuronal level in subsets of INS patients.</p><p>Following our fortuitous observation that acetazolamide, taken to prevent altitude sickness, improved the nystagmus in a subject with hereditary INS, we set out to compare this potential therapy with two other measures that had previously been reported to be effective in this subjectconvergence (or wearing prism spectacles to induce convergence), and contact lenses. Since acetazolamide is known to be an effective treatment for certain inherited, P/Q calcium channel disorders, such as episodic ataxia type 2, our finding raises the question of whether hereditary INS also involves an inherited channelopathy.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MATERIALS AND METHODOLOGY</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Recording</head><p>We used a digital video system (EyeLink II, SR Research, Mississauga, ON, Canada) for the eye-movement recordings. The system had a linear range of ±30 horizontally and ±20</p><p>vertically. System sampling frequency was 500 Hz, and gaze position accuracy error was 0.5 -1 on average. The data from this system were digitized at 500 Hz with 16-bit resolution. The EyeLink signal from each eye was calibrated with the other eye behind cover to obtain accurate position information; the foveation periods were used for calibration. For the contactlens experiment, calibration was done immediately after the subject's prescribed contact lenses were inserted.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Subject and Protocol</head><p>This study was approved by the local IRB and written consent was obtained from the subject before the testing. The subject was a calm 68-year-old male with INS. His nystagmus waveforms were well documented previously and their characteristics representative of others with INS. Because subjects have no voluntary control of their INS waveform characteristics, the data are not affected by subsequent testing. The subject had a convergence "null" and wore either 7 PD base-out prisms added to his refraction (OD: +3.00 S -2.50 C ax 150 and OS: +3.50 S -2.75 C ax 20) or contact lenses with no added prism. His best-corrected distance visual acuities were 20/25 with prisms and 20/40+ with contact lenses. For fixation targets, we use small LED's and reflected laser spots, which are not acuity limiting and yield the same ocular motor data with or without refraction. The subject was seated in a chair with a headrest and a chin stabilizer, far enough (&gt;5 feet) from the stimulus screen to prevent convergence effects. At this distance the target subtended less than 0.1 of visual angle. The room light was turned off during the recording. The contact-lens experiment consisted of five trials performed by the subject while wearing contact lenses; we allowed time between trials for the subject to rest. Each trial tested fixation of horizontal targets from 30° left gaze to 30° right gaze, in 5° steps. We used our standard patient paradigm to test the effects of acetazolamide on this subject. It consists of two trials, one in each direction (as described above), with the target remaining at each gaze angle for 5 sec during both the stepping out laterally and returning to primary position. Subtracting the required target acquisition times, this allows approximately 2-3 sec of steady fixation during each interval. NAFX values are calculated during steady fixations and averaged. This results in a small number of NAFX values at each gaze angle that we have found to be historically very close to each other in value, usually differing in the third decimal place in several studies of many patients. Our paradigm for taking and analyzing such data is based on real-life acquisition and identification of new targets in one's visual field.</p><p>The subject took 500mg of acetazolamide twice a day for three days prior to the study. This dose of drug was chosen because it is the conventional dose for treating glaucoma and idiopathic intracranial hypertension and is usually tolerated with minimal side effects (500 mg to 1000 mg daily, in divided doses). The side effects consisted of transient paraesthesia of the hands (once on day two and once on day three), some abdominal discomfort on day two, and "general, mild discomfort" during days two and three. For comparisons of therapeutic effectiveness, we retrieved data from previous studies using the same subject <ref type="bibr" target="#b4">[5,</ref><ref type="bibr" target="#b9">10]</ref>, who performed the same trials without any refractive correction at far and at near with a convergence angle of 60 PD.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Analysis</head><p>All the analysis was performed in the MATLAB environment (The MathWorks, Natick, MA) using OMLAB software (OMtools, downloadable from http://www.om lab.org). Eye position was sampled directly; it was prefiltered using a low-pass filter with a cutoff frequency of 20 Hz to reduce the noise while minimally affecting the foveation periods. The 20-Hz value is five times the maximum frequency present in foveation periods (0-2 Hz) and still allows separation of foveating and braking saccades from those periods. Analysis was always done on the fixating eye. Segments with inattention or blinking were discarded.</p><p>We analyzed the data using the eXpanded Nystagmus Acuity Function (NAFX) <ref type="bibr" target="#b20">[21]</ref>. It is an extension of the previous Nystagmus Acuity Function (NAF) that consists of a mathematical function containing the following waveform parameters: foveation-period duration, standard deviations of main foveation periods and velocities, and number of cycles in a fixation interval. In the OMtools software, we use the NAFX's graphical user interface for data selection and analysis (details can be obtained from http://www.omlab.org/ OMLAB_page/Teaching/Using_NAFX.html) <ref type="bibr" target="#b21">[22]</ref>. The NAFX provides an objective and repeatable measure of nystagmus foveation quality that accurately predicts the bestcorrected visual acuity possible for subjects without afferent visual system defects, regardless of the eye-movement recording system, the nystagmus type, and waveforms <ref type="bibr" target="#b20">[21]</ref>. In the absence of afferent deficits, the NAFX is highly correlated with measured acuity. We averaged the NAFX values if several were obtained at each gaze angle.</p><p>The longest foveation domain (LFD) <ref type="bibr" target="#b4">[5,</ref><ref type="bibr" target="#b7">8]</ref> is defined as the range of gaze angles in which the subject's NAFX stays above 90% of the NAFX vs Gaze Angle curve's peak value. LFD is a measure of the broadness of the NAFX vs Gaze Angle curve, i.e., the INS subject's high-foveation-quality field.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Computer Simulations</head><p>Ocular motor simulations of the effects of acetazolamide on INS were performed in the MATLAB Simulink (The MathWorks, Natick, MA) environment. The most recent version of our behavioral ocular motor system (OMS) model (version 1.4) is also available from http://www.omlab.org. Details of the model can be found elsewhere <ref type="bibr" target="#b14">[15,</ref><ref type="bibr" target="#b16">17,</ref><ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b22">23]</ref>. To simulate the subject's data, the NAFX peak was set to -2° and the breadth of the NAFX vs Gaze Angle curve was set to be moderate and symmetrical. To simulate the effects of acetazolamide, it was hypothesized to act centrally by reducing the oscillation, originating in the damping control of smooth pursuit, which underlies most INS waveforms.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Subject Data</head><p>During fixation of a distant target, the subject had a peak NAFX of 0.385 at 2° left gaze. As <ref type="figure" target="#fig_0">Fig. (1a)</ref> shows, the  breadth of the NAFX vs Gaze Angle curve given by the LFD function was 20°. When using contact lenses, the NAFX peak was 0.405 with an LFD of 34°, and when converged at 60 PD, the NAFX peak was 0.755 with an LFD of 59°. During distant fixation while taking acetazolamide, the NAFX peak was 0.575 with an LFD of 34°. The NAFX values were slightly more variable for the acetazolamide data (mean standard deviation across gaze angles of 0.101) than for the other three conditions (0.095, 0.089, and 0.026 for distance, contact lenses, and convergence respectively). <ref type="figure" target="#fig_0">Fig.  (1b)</ref> shows examples of the subject's waveforms pre-and post-acetazolamide.</p><p>The percent improvements in the NAFX at each gaze angle for the three therapies are shown in <ref type="figure" target="#fig_2">Fig. (2)</ref>. Each therapy improved the NAFX values by roughly constant percentages within the central ±15° range of gaze angles, 15-40%, 50-100%, and 100-185% for the contact lenses, acetazolamide, and convergence therapies respectively. In addition, the three therapies produced much greater improvements in lateral gaze (600%, 1050%, and 1600%, respectively).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Comparisons to Contact Lenses, Convergence, and Tenotomy and Reattachment</head><p>In addition to comparing the therapeutic effects (on peak NAFX and the LFD) of acetazolamide to contact lenses and convergence therapies, we also compared each to the estimated effects of the T&amp;R based on data from twenty-two patients <ref type="bibr" target="#b5">[6]</ref>. <ref type="figure">Fig. (3a)</ref> demonstrates that acetazolamide raised the peak NAFX by an amount equivalent to that estimated for the T&amp;R procedure, whereas contact lenses fell short while convergence was better. The LFD improvements for both acetazolamide and contact lenses were the same as for the T&amp;R procedure, but less than for convergence ( <ref type="figure">Fig. 3b)</ref>. <ref type="figure" target="#fig_5">Fig. (4)</ref> compares the actual post-therapeutic NAFX and LFD values of each therapy relative to the estimated T&amp;R values.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Computer Simulations</head><p>In order to investigate the possible mechanisms involved in these waveform improvements, we simulated the acetazolamide condition using a behavioral OMS model developed to investigate mechanistic ocular motor hypotheses ranging from normals to individuals with various ocular motor dysfunctions <ref type="bibr" target="#b7">[8,</ref><ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b18">19,</ref><ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref><ref type="bibr" target="#b30">[31]</ref><ref type="bibr" target="#b31">[32]</ref>. In an attempt to mimic the subject's INS characteristics, we used the OMS-model's built-in capabilities to set the NAFX peak to -2° with a symmetrical, medium Alexander's law variation of the INS amplitude with gaze angle. <ref type="figure">Fig. (5)</ref> shows the main components of the OMS model (Smooth Pursuit, Fixation, Saccadic Pulse Generator, Internal Monitor, Fast and Slow Neural Integrators, and Fast and Slow Plant pathways) and of the PMC+ Block (part of the Smooth Pursuit system responsible for its damping). There, we simulated the hypothesized central effect of acetazolamide by reducing the gain factor, "Central Therapy" from 1.3 (the value required to match this subject's pre-acetazolamide INS) to 0.6. As <ref type="figure" target="#fig_6">Fig. (6a)</ref> shows, the simulated INS amplitude increased at gaze angles lateral to -2° (as did the subject's) and the simulated effects of acetazolamide resulted in damped INS waveforms at all gaze angles. Calculating the NAFX values from the simulation data at those gaze angles resulted in a match to the subject's far-fixation data and an improved but not broadened NAFX vs Gaze Angle curve (i.e., the LFD values remained the same) for the simulated effects of acetazolamide <ref type="figure" target="#fig_6">(Fig. 6b)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION AND CONCLUSIONS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acetazolamide</head><p>Acetazolamide, a potent carbonic anhydrase inhibitor is the most common and best-studied agent for the amelioration  <ref type="figure">Fig. (3)</ref>. Comparative plots of a) percent increases in peak NAFX vs Pre-therapy NAFX and b) percent increases in LFD vs pre-therapy LFD during fixation of far targets with contact lenses, with acetazolamide, and during convergence at 60 PD. Curves shown are the estimated percent increases in peak NAFX and LFD for the tenotomy and reattachment (T&amp;R) procedure. The aim of our study is to evaluate if this subject with INS, who took 1000mg/day of acetazolamide for three days to prevent altitude sickness, showed changes in his nystagmus waveforms. However, this subject's INS waveforms at each gaze angle were unchanged by acetazolamide, as they have been since his first eye-movement recording in the mid 1960's (compare also the original "null" position shown in <ref type="figure" target="#fig_0">Figs. (1, 2)</ref> with the more recent NAFX peaks and % NAFXimprovement troughs). Such intra-subject consistency is common, despite inter-subject variability, and has been documented in many patients who have had repeat studies in our laboratory years, or even decades, apart. Although acetazolamide did improve the average NAFX values over contact lenses, there was more variability at each gaze angle (possibly related to the subject's mild discomfort); this and the other the side effects might be contraindications to using acetazolamide (at the dosage used) as a therapy for INS. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Underlying Mechanisms</head><p>Ocular motility studies of INS have demonstrated that, despite minor idiosyncrasies and whether or not there is an associated visual abnormality or it is hereditary, all INS is the same disorder (i.e., the same common waveforms and their characteristic variations with gaze and vergence angles). Thus, the ocular motor system instability is indistinguishable between patient subpopulations and has the same direct, functional cause (e.g., loss of pursuit-system damping). As is evident from the literature, the terminology used and the questions posed when discussing the "cause" of a disorder often reflect one's training or approach to the problem. The geneticist speaks of a genetic abnormality, the physiologist or anatomist, of the misbehavior of a group of cells, their absence, or misrouting of their connections, and the control-systems analysist, of an unstable feedback loop. However, such diverse putative "causes" of a condition may be neither contradictory nor repetitious. Rather, each is a meaningful description to those with the corresponding background, while the other descriptions may seem somehow lacking. Going from initial speculation to a realistic hypothesis for INS requires establishing a functional connection between the putative "cause" and the resulting eye oscillation and ocular motor behavior. For example, in some with INS, a genetic abnormality or spontaneous occurrence could result in a channelopathy of the subset of cells that set the smooth-pursuit damping gain. Other INS patients might have calibration of that gain altered by lack of adequate visual input, still others by another physiological or anatomical disorder of the cells controlling pursuit damping. In all of these putative scenarios, the INS instability will be indistinguishable among patients, the direct, functional cause will be the same, but the precipitating factors and lower level mechanisms will differ.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Comparative Therapies</head><p>As <ref type="figure" target="#fig_5">Figs. (3, 4)</ref> shows, there are broad ranges of initial NAFX and LFD values within which the T&amp;R procedure produces significant improvements (e.g., 0.05 NAFX 0.6 and 2.5° LFD 25°). This use of accurate eye-movement data to diagnose INS and determine the therapeutic approach with the maximal therapeutic efficacy has also resulted in an analysis procedure whereby we can estimate a priori the percent improvement and final values for both the NAFX and LFD; the former also allows estimation of the improvement in measured (not just potential) visual acuity of <ref type="figure">Fig. (5)</ref>. Block diagrams of the behavioral ocular motor system model and the PMC+ block (controlling damping within the Smooth Pursuit system) where the hypothesized central effect of acetazolamide was simulated. The gain factor "Central Therapy" (lower input to the final multiplier) was adjusted downward from its pre-acetazolamide value of 1.3.</p><p>INS patients with or without afferent visual deficits <ref type="bibr" target="#b5">[6]</ref>. The present study demonstrates how, for an individual patient, we can determine the relative improvements of several different types of therapies and compare them to the estimated improvement from the T&amp;R procedure. The effects of this drug are independent of, and act at different sites from, either convergence or gaze-angle nulls. Therefore, the presence or absence of convergence or gazeangle nulls would not alter the effects of the drug on INS. Therapeutic effects of such diverse treatments have been shown to be multiplicative, acting in different ways at different sites. This is the first time objective INS eyemovement data analyses have been used for these purposes.</p><p>The outcome data from vergence prisms also represents the results of performing a bimedial rectus recession procedure, since the resulting induced convergence to align the eyes has equivalent effects on INS in the two cases. Our research has shown that it is the act of convergence that damps INS in those patients who demonstrate this effect. That act of convergence is the same whether or not it is induced by prisms or by a surgically induced divergence. The static concept of "weakening" a muscle is of little use in understanding the dynamic effects of most eye-muscle surgery or vergence on an oscillation like INS. Although the antagonist muscles of each eye receive different innervations for convergence, the resultant force is equal in each muscle. Rather, it is alteration of the proprioceptively controlled resting muscle tension that is responsible. In fact, we test for the efficacy of the bimedial rectus recession procedure in binocular patients with an INS convergence null by having them wear BO prisms. Also, due to the fact that the muscles wrap around the equator and attach closer to the cornea, small recessions do not substantially weaken the mechanical advantage of the muscle. The different innervations of the EOM during convergence result in equal and opposite forces in the two antagonist muscles of each eye and are not what reduces their small-signal gain. Prism-induced vergence produces the same broadening effects as the T&amp;R procedure, implying the same mechanism of action and removing the requirement for the addition of bilateral rectus muscle T&amp;R to the bimedial rectus recession procedure. Based on our analyses of hundreds of INS patients, where convergence nulls have always been greater than gaze-angle nulls, we concluded long ago that inducing convergence in binocular patients with convergence damping would have greater therapeutic improvement than any other known therapyeither base-out prisms or the bimedial rectus recession procedure should be the therapy of choice in these patients. Because the eye-movement data from this subject are representative of the INS population in general, if surgery were to be considered for the subject of this study, maximal therapeutic improvement would result from a bimedial rectus recession procedure. There is no evidence that inducing convergence by either method will cause strabismus in these binocular patients; both therapies have resulted in large, sustained improvements in visual function. Further neurophysiological study of convergence's effects on proprioception is needed to clarify the specific mechanism involved.</p><p>The past four decades of INS research suggests that the direct, functional cause of INS is the miscalibration of smooth-pursuit damping <ref type="bibr" target="#b13">[14,</ref><ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b27">28]</ref>. Therapies may either be directed: 1) afferently to alleviate the visual condition that interfered with damping calibration <ref type="bibr" target="#b32">[33]</ref><ref type="bibr" target="#b33">[34]</ref><ref type="bibr" target="#b34">[35]</ref>; 2) centrally at the cells responsible for damping miscalibration (as some drugs may do, although they may also act elsewhere with possibly undesirable side effects) <ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref>; or 3) peripherally to reduce the effects of the underlying instability (e.g., vergence prisms, contact lenses, or the T&amp;R procedure) <ref type="bibr" target="#b6">[7,</ref><ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b35">36]</ref>. It is unclear whether acetazolamide affected a channelopathy in a subset of central or peripheral neurons (i.e., whether it affected the "cause" or merely ameliorated the "effect"-as does the T&amp;R procedure). Finally, to the extent that one particular type of therapy insufficiently improves the INS waveform, other types may be added that will multiply the therapeutic improvement <ref type="bibr" target="#b36">[37]</ref>.</p><p>Recent work on the pathogenesis of some hereditary forms of INS has focused on the FRMD7 gene, which is expressed in retina and cerebellum. Exactly how mutations of this gene could cause INS is debated, although the cerebellum plays an important role in smooth tracking eye movements and gaze holding. Future studies aimed at investigating whether ion channels or specific neurotransmitters are affected by the FRMD7 gene may lead to identifying more specific drug therapies for hereditary INS <ref type="bibr" target="#b37">[38]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Computer Simulations</head><p>We used computer simulations to explore a possible mechanism of action of acetazolamide in this subject's INS. After simulating the subject's INS waveform variation with gaze angle, we investigated the effects on INS of simply reducing the oscillatory signal in the smooth-pursuit damping circuitry (no other changes to the model were made). That is, we hypothesized that acetazolamide has the single ocular motor effect of centrally damping the causal INS oscillation. Analysis of the simulated results produced an NAFX vs Gaze Angle curve that was higher (i.e., allowing better visual acuity) but not wider (i.e., allowing high acuity over more gaze angles). This did not accurately simulate the subject's data, which showed both improvements. Thus, this single-site hypothesis for the effects of acetazolamide on this subject was disproven; i.e., the model suggested that acetazolamide's action was not limited to only that ocular motor site. This should not be surprising, given its systemic actions as evidenced by the unrelated side effects.</p><p>Our computer simulations demonstrated that a central reduction in the magnitude of the initial INS instability was insufficient to mimic the measured INS-waveform improvements and suggested that acetazolamide also acts centrally at another site to broaden the Alexander's law variation of INS amplitude. That combination could be simulated in the same way the pre-acetazolamide simulation was matched to the subject's far-fixation data. A third possibility is that acetazolamide acted peripherally and therefore, affected INS in a manner similar to that of the T&amp;R procedure; we have already simulated and reported those peripheral therapeutic effects <ref type="bibr" target="#b19">[20]</ref>. Finally, acetazolamide could have acted both centrally and peripherally.</p><p>The efficacy of acetazolamide as a therapy requires studies at a reduced dosage to determine if its therapeutic effects can be maintained without side effects. In addition, the repeatability of its effects over time and the number and type of patients (i.e., other than those with hereditary INS) in whom it is effective need to be determined. Other, similar drugs (e.g., methazolamide) should also be investigated. The results of this preliminary study provide a foundation for a randomized, double-blind, drug-efficacy study of these drugs in patients with INS and a comparison to the known effects of other drugs on INS <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b11">12]</ref> and to the known surgical effects.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. ( 1 )</head><label>1</label><figDesc>. a) Plots of NAFX vs Gaze Angle during fixation of far targets with no therapeutic aids, with contact lenses, with acetazolamide, and during convergence at 60 PD. The equivalent visual acuities shown are for subjects over 60 years of age. Curves are 2 nd order polynomial fits to the data. N = "null" originally measured in 1963. b) Examples of the pre-and post-acetazolamide (heavy line) INS waveforms. Large spikes are blinks or video dropouts.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc>Poly. (Far) Poly. (Far with Contacts) Poly. (Far with Acetazolamide)Poly. (Conv @ 60 PD)</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. ( 2 )</head><label>2</label><figDesc>. Plots of Percent Improvement in NAFX vs Gaze Angle during fixation of far targets with contact lenses, with acetazolamide, and during convergence at 60 PD. Curves are 6 th order polynomial fits to the data. N = "null" originally measured in 1963.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head></head><label></label><figDesc>of acute mountain sickness; it also is used in the treatment of idiopathic intracranial hypertension and as adjunctive treatment for primary open angle glaucoma.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Fig. ( 4 ).</head><label>4</label><figDesc>Comparative plots of a) post-therapy peak NAFX vs pre-therapy peak NAFX and b) post-therapy LFD vs pre-therapy LFD during fixation of far targets with contact lenses, with acetazolamide, and during convergence at 60 PD. Curves shown are the estimated peak NAFX and LFD for the tenotomy and reattachment (T&amp;R) procedure.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Fig. ( 6</head><label>6</label><figDesc>). (a) Plots of OMS model outputs simulating far fixation at 0°, ±10°, and ±20° for both the pre-and post-acetazolamide (heavy line) conditions. (b) Plots of NAFX vs Gaze Angle for the simulated data in (a). Shown for comparison is the Far curve from the subject's data.</figDesc></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGEMENT</head><p>This work was supported in part by the Office of Research and Development, Medical Research Service, Department of Veterans Affairs.</p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">A National Eye Institute Sponsored Workshop and Publication on The Classification of Eye Movement Abnormalities and Strabismus (CEMAS)</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Cemas_Working_Group</surname></persName>
		</author>
		<ptr target="http://www.nei.nih.gov/news/statements/cemas.pdf" />
	</analytic>
	<monogr>
		<title level="j">National Institutes of Health</title>
		<imprint>
			<date type="published" when="2001" />
		</imprint>
	</monogr>
	<note>In: The National Eye Institute Publications. last accessed, 6/15/10</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Congenital Nystagmus Waveforms and Foveation Strategy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">F</forename><surname>Dell'osso</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">B</forename><surname>Daroff</surname></persName>
		</author>
		<idno type="DOI">10.1007/978-3-642-48446-9_52</idno>
	</analytic>
	<monogr>
		<title level="m">Symposien der Deutschen Ophthalmologischen Gesellschaft</title>
		<imprint>
			<publisher>J.F. Bergmann-Verlag</publisher>
			<date type="published" when="1978" />
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="353" to="356" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Clinical and genetic analysis of a family with X-linked congenital nystagmus (NYS1)</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">B</forename><surname>Kerrison</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Roberto</forename><surname>Giorda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Thomas</forename><forename type="middle">D</forename><surname>Lenart</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Arlene</forename><forename type="middle">V</forename><surname>Drack</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Irene</forename><forename type="middle">H</forename><surname>Maumenee</surname></persName>
		</author>
		<idno type="DOI">10.1076/opge.22.4.241.2216</idno>
		<idno type="PMID">11803490</idno>
	</analytic>
	<monogr>
		<title level="j">Ophthalmic Genetics</title>
		<title level="j" type="abbrev">Ophthalmic Genetics</title>
		<idno type="ISSN">1381-6810</idno>
		<idno type="ISSNe">1744-5094</idno>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="241" to="248" />
			<date type="published" when="2001-01" />
			<publisher>Swets &amp; Zeitlinger Publishers</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">FIXATION CHARACTERISTICS IN HEREDITARY CONGENITAL NYSTAGMUS</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">F</forename><surname>Dell'osso</surname></persName>
		</author>
		<idno type="DOI">10.1097/00006324-197302000-00001</idno>
	</analytic>
	<monogr>
		<title level="j">Optometry and Vision Science</title>
		<title level="j" type="abbrev">Optometry and Vision Science</title>
		<idno type="ISSN">1040-5488</idno>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="85" to="90" />
			<date type="published" when="1973-02" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Combined Gaze-Angle and Vergence Variation in Infantile Nystagmus: Two Therapies That Improve the High-Visual-Acuity Field and Methods to Measure It</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alessandro</forename><surname>Serra</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Louis</forename><forename type="middle">F</forename><surname>Dell’osso</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jonathan</forename><forename type="middle">B</forename><surname>Jacobs</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">A</forename><surname>Burnstine</surname></persName>
		</author>
		<idno type="DOI">10.1167/iovs.05-1320</idno>
		<idno type="PMID">16723456</idno>
		<ptr type="open-access" target="https://iovs.arvojournals.org/data/journals/iovs/932938/z7g00606002451.pdf" />
	</analytic>
	<monogr>
		<title level="j">Investigative Opthalmology &amp; Visual Science</title>
		<title level="j" type="abbrev">Invest. Ophthalmol. Vis. Sci.</title>
		<idno type="ISSN">1552-5783</idno>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">2451</biblScope>
			<date type="published" when="2006-06-01" />
			<publisher>Association for Research in Vision and Ophthalmology (ARVO)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">A Review of the Tenotomy Nystagmus Surgery: Origin, Mechanism, and General Efficacy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><forename type="middle">I</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">F</forename><surname>Dell'osso</surname></persName>
		</author>
		<idno type="DOI">10.1080/01658100701647704</idno>
	</analytic>
	<monogr>
		<title level="j">Neuro-Ophthalmology</title>
		<title level="j" type="abbrev">Neuro-Ophthalmology</title>
		<idno type="ISSN">0165-8107</idno>
		<idno type="ISSNe">1744-506X</idno>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">5-6</biblScope>
			<biblScope unit="page" from="157" to="165" />
			<date type="published" when="2007-01" />
			<publisher>Informa UK Limited</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Horizontal rectus tenotomy in patients with congenital nystagmus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><forename type="middle">W</forename><surname>Hertle</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Louis</forename><forename type="middle">F</forename><surname>Dell'osso</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Edmond</forename><forename type="middle">J</forename><surname>Fitzgibbon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Darby</forename><surname>Thompson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dongsheng</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Susan</forename><forename type="middle">D</forename><surname>Mellow</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0161-6420(03)00802-9</idno>
		<idno type="PMID">14597515</idno>
	</analytic>
	<monogr>
		<title level="j">Ophthalmology</title>
		<title level="j" type="abbrev">Ophthalmology</title>
		<idno type="ISSN">0161-6420</idno>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="2097" to="2105" />
			<date type="published" when="2003-11" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Effects of tenotomy on patients with infantile nystagmus syndrome: Foveation improvement over a broadened visual field</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zhong</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Louis</forename><forename type="middle">F</forename><surname>Dell’osso</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jonathan</forename><forename type="middle">B</forename><surname>Jacobs</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">A</forename><surname>Burnstine</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">L</forename><surname>Tomsak</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jaapos.2006.08.021</idno>
		<idno type="PMID">17189150</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of American Association for Pediatric Ophthalmology and Strabismus</title>
		<title level="j" type="abbrev">Journal of American Association for Pediatric Ophthalmology and Strabismus</title>
		<idno type="ISSN">1091-8531</idno>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="552" to="560" />
			<date type="published" when="2006-12" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Combining recessions (nystagmus and strabismus) with tenotomy improved visual function and decreased oscillopsia and diplopia in acquired downbeat nystagmus and in horizontal infantile nystagmus syndrome</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zhong</forename><forename type="middle">I</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Louis</forename><forename type="middle">F</forename><surname>Dell’osso</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">L</forename><surname>Tomsak</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jonathan</forename><forename type="middle">B</forename><surname>Jacobs</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jaapos.2006.10.012</idno>
		<idno type="PMID">17280849</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of American Association for Pediatric Ophthalmology and Strabismus</title>
		<title level="j" type="abbrev">Journal of American Association for Pediatric Ophthalmology and Strabismus</title>
		<idno type="ISSN">1091-8531</idno>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="135" to="141" />
			<date type="published" when="2007-04" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Infantile nystagmus syndrome: broadening the high-foveation-quality field with contact lenses</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Taibbi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><forename type="middle">I</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">F</forename><surname>Dell'osso</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Ophthalmol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="585" to="90" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Pharmacologic Treatment of Congenital Nystagmus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Sarvananthan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">A</forename><surname>Proudlock</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Choudhuri</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Dua</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Gottlob</surname></persName>
		</author>
		<idno type="DOI">10.1001/archopht.124.6.916</idno>
		<idno type="PMID">16769853</idno>
		<ptr type="open-access" target="https://jamanetwork.com/journals/jamaophthalmology/articlepdf/417706/ecr0606-5-1.pdf" />
	</analytic>
	<monogr>
		<title level="j">Archives of Ophthalmology</title>
		<title level="j" type="abbrev">Arch Ophthalmol</title>
		<idno type="ISSN">0003-9950</idno>
		<imprint>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">916</biblScope>
			<date type="published" when="2006-06-01" />
			<publisher>American Medical Association (AMA)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">The effects of gabapentin and memantine in acquired and congenital nystagmus: a retrospective study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Shery</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">A</forename><surname>Proudlock</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Sarvananthan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">J</forename><surname>Mclean</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Gottlob</surname></persName>
		</author>
		<idno type="DOI">10.1136/bjo.2005.086322</idno>
		<idno type="PMID">16556621</idno>
		<idno type="PMCID">PMC1857134</idno>
		<idno type="ark">ark:/67375/NVC-RXZBVLHV-M</idno>
		<idno type="istexId">E46902DDF59BF61C5385992042B848505C30A5E1</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc1857134?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">British Journal of Ophthalmology</title>
		<title level="j" type="abbrev">British Journal of Ophthalmology</title>
		<idno type="ISSN">0007-1161</idno>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="839" to="843" />
			<date type="published" when="2006-07-01" />
			<publisher>BMJ</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Congenital nystagmus: Randomized, controlled, double-masked trial of memantine/gabapentin</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rebecca</forename><surname>Mclean</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Frank</forename><surname>Proudlock</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shery</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chris</forename><surname>Degg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Irene</forename><surname>Gottlob</surname></persName>
		</author>
		<idno type="DOI">10.1002/ana.21065</idno>
		<idno type="PMID">17279539</idno>
		<idno type="ark">ark:/67375/WNG-X948BRST-0</idno>
		<idno type="istexId">B66081F66013E8608C803ED648DD9378E64C5932</idno>
	</analytic>
	<monogr>
		<title level="j">Annals of Neurology</title>
		<title level="j" type="abbrev">Ann Neurol.</title>
		<idno type="ISSN">0364-5134</idno>
		<idno type="ISSNe">1531-8249</idno>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="130" to="138" />
			<date type="published" when="2007-02" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<monogr>
		<title level="m" type="main">Normal models that simulate dysfunction</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">F</forename><surname>Dell'osso</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Nystagmus</surname></persName>
		</author>
		<editor>Hung GK Ciuffreda KJ</editor>
		<imprint>
			<date type="published" when="2002" />
			<publisher>Kluwer Academic/Plenum Publishers</publisher>
			<biblScope unit="page" from="711" to="750" />
			<pubPlace>New York</pubPlace>
		</imprint>
	</monogr>
	<note>Models of the Visual System</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Congenital nystagmus: Hypotheses for its genesis and complex waveforms within a behavioral ocular motor system model</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jonathan</forename><forename type="middle">B</forename><surname>Jacobs</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Louis</forename><forename type="middle">F</forename><surname>Dell’osso</surname></persName>
		</author>
		<idno type="DOI">10.1167/4.7.7</idno>
		<idno type="PMID">15330705</idno>
		<ptr type="open-access" target="https://jov.arvojournals.org/data/journals/jov/933506/jov-4-7-7.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Vision</title>
		<title level="j" type="abbrev">Journal of Vision</title>
		<idno type="ISSN">1534-7362</idno>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page">7</biblScope>
			<date type="published" when="2004-07-27" />
			<publisher>Association for Research in Vision and Ophthalmology (ARVO)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Being “slow to see” is a dynamic visual function consequence of infantile nystagmus syndrome: Model predictions and patient data identify stimulus timing as its cause</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><forename type="middle">I</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">F</forename><surname>Dell’osso</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.visres.2007.01.008</idno>
		<idno type="PMID">17328937</idno>
	</analytic>
	<monogr>
		<title level="j">Vision Research</title>
		<title level="j" type="abbrev">Vision Research</title>
		<idno type="ISSN">0042-6989</idno>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1550" to="1560" />
			<date type="published" when="2007-05" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Factors influencing pursuit ability in infantile nystagmus syndrome: Target timing and foveation capability</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><forename type="middle">I</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">F</forename><surname>Dell’osso</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.visres.2008.10.007</idno>
		<idno type="PMID">18996408</idno>
	</analytic>
	<monogr>
		<title level="j">Vision Research</title>
		<title level="j" type="abbrev">Vision Research</title>
		<idno type="ISSN">0042-6989</idno>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="182" to="189" />
			<date type="published" when="2009-01" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">A new surgery for congenital nystagmus: Effects of tenotomy on an achiasmatic canine and the role of extraocular proprioception</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Louis</forename><forename type="middle">F</forename><surname>Dell'osso</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><forename type="middle">W</forename><surname>Hertle</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">W</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jonathan</forename><forename type="middle">B</forename><surname>Jacobs</surname></persName>
		</author>
		<idno type="DOI">10.1016/s1091-8531(99)70063-7</idno>
		<idno type="PMID">10428591</idno>
		<idno type="PII">S1091-8531(99)70063-7</idno>
		<idno type="ark">ark:/67375/6H6-WM9VS554-J</idno>
		<idno type="istexId">2A901AA454E62D5B190738E631EFA039450F5E50</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of American Association for Pediatric Ophthalmology and Strabismus</title>
		<title level="j" type="abbrev">Journal of American Association for Pediatric Ophthalmology and Strabismus</title>
		<idno type="ISSN">1091-8531</idno>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="166" to="182" />
			<date type="published" when="1999-06" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Tenotomy does not affect saccadic velocities: Support for the “small-signal” gain hypothesis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">F</forename><surname>Dell’osso</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">J</forename><surname>Leigh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">B</forename><surname>Jacobs</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.visres.2006.01.008</idno>
		<idno type="PMID">16497352</idno>
	</analytic>
	<monogr>
		<title level="j">Vision Research</title>
		<title level="j" type="abbrev">Vision Research</title>
		<idno type="ISSN">0042-6989</idno>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="issue">14</biblScope>
			<biblScope unit="page" from="2259" to="2267" />
			<date type="published" when="2006-07" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Tenotomy procedure alleviates the “slow to see” phenomenon in infantile nystagmus syndrome: Model prediction and patient data</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><forename type="middle">I</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">F</forename><surname>Dell’osso</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.visres.2008.03.007</idno>
		<idno type="PMID">18442840</idno>
	</analytic>
	<monogr>
		<title level="j">Vision Research</title>
		<title level="j" type="abbrev">Vision Research</title>
		<idno type="ISSN">0042-6989</idno>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1409" to="1419" />
			<date type="published" when="2008-06" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">An expanded nystagmus acuity function: intra-and intersubject prediction of best-corrected visual acuity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">F</forename><surname>Dell'osso</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">B</forename><surname>Jacobs</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Doc Ophthalmol</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="page" from="249" to="76" />
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Using the NAFX for eye-movement fixation data analysis and display</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">F</forename><surname>Dell'osso</surname></persName>
		</author>
		<ptr target="http://www.omlab.org/OMLAB_page/Teaching/teaching.html" />
	</analytic>
	<monogr>
		<title level="j">OMLAB Report</title>
		<imprint>
			<biblScope unit="volume">111005</biblScope>
			<biblScope unit="page" from="1" to="7" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
	<note>Last accessed, 6/15/10</note>
</biblStruct>

<biblStruct xml:id="b22">
	<monogr>
		<title level="m" type="main">A unifying hypothesis for the multiple waveforms of infantile nystagmus and their idiosyncratic variation with gaze angle and therapy. (Ph.D. Dissertation), In Biomedical Engineering</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><forename type="middle">I</forename><surname>Wang</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2008" />
			<biblScope unit="page" from="1" to="359" />
			<pubPlace>Cleveland</pubPlace>
		</imprint>
		<respStmt>
			<orgName>Case Western Reserve University</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">A Dual-Mode Model for the Normal Eye Tracking System and the System with Nystagmus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">F</forename><surname>Dell'osso</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Ph.D. Dissertation)</title>
		<meeting><address><addrLine>Laramie</addrLine></address></meeting>
		<imprint>
			<date type="published" when="1968" />
			<biblScope unit="page" from="1" to="131" />
		</imprint>
		<respStmt>
			<orgName>In Electrical Engineering (Biomedical). University of Wyoming</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">A robust, normal ocular motor system model with congenital nystagmus (CN) including braking and foveating saccades</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">F</forename><surname>Dell'osso</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">B</forename><surname>Jacobs</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Medimond Medical Publications: Englewood</title>
		<editor>Sharpe JA, Ed</editor>
		<imprint>
			<biblScope unit="page" from="107" to="118" />
			<date type="published" when="2000" />
		</imprint>
	</monogr>
	<note>Neuro-ophthalmology at the Beginning of the New Millennium</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">A robust, normal ocular motor system model with latent/manifest latent nystagmus (LMLN) and dual-mode fast phases</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">F</forename><surname>Dell'osso</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">B</forename><surname>Jacobs</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Medimond Medical Publications: Englewood</title>
		<editor>Sharpe JA, Ed</editor>
		<imprint>
			<biblScope unit="page" from="113" to="131" />
			<date type="published" when="2000" />
		</imprint>
	</monogr>
	<note>Neuro-ophthalmology at the Beginning of the New Millennium</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">A normal ocular motor system model that simulates the dual-mode fast phases of latent/manifest latent nystagmus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">F</forename><surname>Dell'osso</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">B</forename><surname>Jacobs</surname></persName>
		</author>
		<idno type="DOI">10.1007/s004220100275</idno>
		<idno type="PMID">11762236</idno>
		<idno type="ark">ark:/67375/VQC-23GP05CN-M</idno>
		<idno type="istexId">95F16F8A45FCBB10809FF03F9629071128E5FD0A</idno>
	</analytic>
	<monogr>
		<title level="j">Biological Cybernetics</title>
		<title level="j" type="abbrev">Biological Cybernetics</title>
		<idno type="ISSN">0340-1200</idno>
		<idno type="ISSNe">1432-0770</idno>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="459" to="471" />
			<date type="published" when="2001-12-01" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<monogr>
		<title level="m" type="main">An Ocular Motor System Model that Simulates Congenital Nystagmus, Including Braking and Foveating Saccades. (Ph.D. Dissertation), In Biomedical Engineering</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">B</forename><surname>Jacobs</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2001" />
			<biblScope unit="page" from="1" to="357" />
			<pubPlace>Cleveland</pubPlace>
		</imprint>
		<respStmt>
			<orgName>Case Western Reserve University</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">A Robust, Normal Ocular Motor System Model with Latent/Manifest Latent Nystagmus and Dual-Mode Fast Phases</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jonathan</forename><forename type="middle">B</forename><surname>Jacobs</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Louis</forename><forename type="middle">F</forename><surname>Dell'osso</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1749-6632.2002.tb02895.x</idno>
		<idno type="PMID">11960880</idno>
		<idno type="ark">ark:/67375/WNG-NCHXP6V8-2</idno>
		<idno type="istexId">642B2C157D19F98A46632BEC48E9A2B6D1CF5F17</idno>
	</analytic>
	<monogr>
		<title level="j">Annals of the New York Academy of Sciences</title>
		<editor>Kaminski HJ Leigh RJ</editor>
		<idno type="ISSN">0077-8923</idno>
		<idno type="ISSNe">1749-6632</idno>
		<imprint>
			<biblScope unit="volume">956</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="604" to="607" />
			<date type="published" when="2002-04" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
	<note>Ann NY Acad Sci</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Biologically Relevant Models of Infantile Nystagmus Syndrome: The Requirement for Behavioral Ocular Motor System Models</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">F</forename><surname>Dell'osso</surname></persName>
		</author>
		<idno type="DOI">10.1080/08820530600613795</idno>
		<idno type="PMID">16702072</idno>
	</analytic>
	<monogr>
		<title level="j">Seminars in Ophthalmology</title>
		<title level="j" type="abbrev">Seminars in Ophthalmology</title>
		<idno type="ISSN">0882-0538</idno>
		<idno type="ISSNe">1744-5205</idno>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="71" to="77" />
			<date type="published" when="2006-01" />
			<publisher>Informa UK Limited</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">A unifying hypothesis for both pendular and jerk waveforms in infantile nystagmus embodied in a behavioral ocular motor system model</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">F</forename><surname>Dell'osso</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">B</forename><surname>Jacobs</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Proceedngs of the WMSCI 2006 Conference. Int Inst Informatics Systemics</title>
		<editor>Callaos N, Lesso W, Ham C, Dell&apos;Osso LF, Li Z</editor>
		<meeting>eedngs of the WMSCI 2006 Conference. Int Inst Informatics Systemics<address><addrLine>Orlando, FL</addrLine></address></meeting>
		<imprint>
			<date type="published" when="2006" />
			<biblScope unit="page" from="51" to="57" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Expanding the original behavioral infantile nystagmus syndrome model to jerk waveforms and gaze-angle variations</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><forename type="middle">I</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">F</forename><surname>Dell'osso</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">B</forename><surname>Jacobs</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Advances in Understanding Mechanisms and Treatment of Congenital Forms of Nystagmus</title>
		<editor>Leigh RJ, Devereaux MW</editor>
		<meeting><address><addrLine>New York</addrLine></address></meeting>
		<imprint>
			<publisher>Oxford University Press</publisher>
			<date type="published" when="2008" />
			<biblScope unit="page" from="139" to="181" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Reversal of Blindness in Animal Models of Leber Congenital Amaurosis Using Optimized AAV2-mediated Gene Transfer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jeannette</forename><surname>Bennicelli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">Fraser</forename><surname>Wright</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andras</forename><surname>Komaromy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jonathan</forename><forename type="middle">B</forename><surname>Jacobs</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bernd</forename><surname>Hauck</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Olga</forename><surname>Zelenaia</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Federico</forename><surname>Mingozzi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Daniel</forename><surname>Hui</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Daniel</forename><surname>Chung</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tonia</forename><forename type="middle">S</forename><surname>Rex</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zhangyong</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Guang</forename><surname>Qu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shangzhen</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Caroline</forename><surname>Zeiss</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Valder</forename><forename type="middle">R</forename><surname>Arruda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gregory</forename><forename type="middle">M</forename><surname>Acland</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lou</forename><forename type="middle">F</forename><surname>Dell'osso</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Katherine</forename><forename type="middle">A</forename><surname>High</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Albert</forename><forename type="middle">M</forename><surname>Maguire</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jean</forename><surname>Bennett</surname></persName>
		</author>
		<idno type="DOI">10.1038/sj.mt.6300389</idno>
		<idno type="PMID">18209734</idno>
		<idno type="PMCID">PMC2842085</idno>
	</analytic>
	<monogr>
		<title level="j">Molecular Therapy</title>
		<title level="j" type="abbrev">Molecular Therapy</title>
		<idno type="ISSN">1525-0016</idno>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="458" to="465" />
			<date type="published" when="2008-03" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Eye movement recordings as an effectiveness indicator of gene therapy in RPE65-deficient canines: implications for the ocular motor system</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">B</forename><surname>Jacobs</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">F</forename><surname>Dell’osso</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">W</forename><surname>Hertle</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">M</forename><surname>Acland</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Bennett</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jaapos.2006.10.006</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of American Association for Pediatric Ophthalmology and Strabismus</title>
		<title level="j" type="abbrev">Journal of American Association for Pediatric Ophthalmology and Strabismus</title>
		<idno type="ISSN">1091-8531</idno>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">599</biblScope>
			<date type="published" when="2006-12" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Safety and Efficacy of Gene Transfer for Leber&apos;s Congenital Amaurosis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Albert</forename><forename type="middle">M</forename><surname>Maguire</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Francesca</forename><surname>Simonelli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eric</forename><forename type="middle">A</forename><surname>Pierce</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Edward</forename><forename type="middle">N</forename><surname>Pugh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Federico</forename><surname>Mingozzi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jeannette</forename><surname>Bennicelli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sandro</forename><surname>Banfi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kathleen</forename><forename type="middle">A</forename><surname>Marshall</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Francesco</forename><surname>Testa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Enrico</forename><forename type="middle">M</forename><surname>Surace</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Settimio</forename><surname>Rossi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Arkady</forename><surname>Lyubarsky</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Valder</forename><forename type="middle">R</forename><surname>Arruda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Barbara</forename><surname>Konkle</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Edwin</forename><surname>Stone</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Junwei</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jonathan</forename><surname>Jacobs</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lou</forename><surname>Dell'osso</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><surname>Hertle</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jian-Xing</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">Michael</forename><surname>Redmond</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiaosong</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bernd</forename><surname>Hauck</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Olga</forename><surname>Zelenaia</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kenneth</forename><forename type="middle">S</forename><surname>Shindler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Maureen</forename><forename type="middle">G</forename><surname>Maguire</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">Fraser</forename><surname>Wright</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nicholas</forename><forename type="middle">J</forename><surname>Volpe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jennifer</forename><forename type="middle">Wellman</forename><surname>Mcdonnell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alberto</forename><surname>Auricchio</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Katherine</forename><forename type="middle">A</forename><surname>High</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jean</forename><surname>Bennett</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejmoa0802315</idno>
		<idno type="PMID">18441370</idno>
		<idno type="PMCID">PMC2829748</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc2829748?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">New England Journal of Medicine</title>
		<title level="j" type="abbrev">N Engl J Med</title>
		<idno type="ISSN">0028-4793</idno>
		<idno type="ISSNe">1533-4406</idno>
		<imprint>
			<biblScope unit="volume">358</biblScope>
			<biblScope unit="issue">21</biblScope>
			<biblScope unit="page" from="2240" to="2248" />
			<date type="published" when="2008-05-22" />
			<publisher>New England Journal of Medicine (NEJM/MMS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Contact lenses and congenital nystagmus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">F</forename><surname>Dell'osso</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Traccis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">A</forename><surname>Abel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">I</forename><surname>Erzurum</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Vision Sci</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="229" to="261" />
			<date type="published" when="1988" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Treatment of acquired pendular nystagmus from multiple sclerosis with eye muscle surgery followed by oral memantine</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">L</forename><surname>Tomsak</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">F</forename><surname>Dell'osso</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">C</forename><surname>Rucker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">J</forename><surname>Leigh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">C</forename><surname>Bienfang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">B</forename><surname>Jacobs</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">DJO</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="1" to="11" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Phenotypical characteristics of idiopathic infantile nystagmus with and without mutations in FRMD7</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shery</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Frank</forename><forename type="middle">A</forename><surname>Proudlock</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nagini</forename><surname>Sarvananthan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eryl</forename><forename type="middle">O</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Musarat</forename><surname>Awan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rebecca</forename><surname>Mclean</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mylvaganam</forename><surname>Surendran</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">S</forename><surname>Anil Kumar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shegufta</forename><forename type="middle">J</forename><surname>Farooq</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chris</forename><surname>Degg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><forename type="middle">P</forename><surname>Gale</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">D</forename><surname>Reinecke</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Geoffrey</forename><surname>Woodruff</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrea</forename><surname>Langmann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Susanne</forename><surname>Lindner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sunila</forename><surname>Jain</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Patrick</forename><surname>Tarpey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">Lucy</forename><surname>Raymond</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Irene</forename><surname>Gottlob</surname></persName>
		</author>
		<idno type="DOI">10.1093/brain/awn046</idno>
		<idno type="PMID">18372314</idno>
		<idno type="ark">ark:/67375/HXZ-24FFBL8G-3</idno>
		<idno type="istexId">022DCBD46C980068FEC9FF998C4F4E8DCF75D66D</idno>
		<ptr type="open-access" target="https://academic.oup.com/brain/article-pdf/131/5/1259/16695406/awn046.pdf" />
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<idno type="ISSN">0006-8950</idno>
		<idno type="ISSNe">1460-2156</idno>
		<imprint>
			<biblScope unit="volume">131</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1259" to="1267" />
			<date type="published" when="2008-03-27" />
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
